IceCure presents hat-trick of positive trial data for cryoablation device
IceCure Medical has reported data from three clinical trials, showcasing the efficacy of its ProSense cryoablation device in the treatment…
IceCure Medical has reported data from three clinical trials, showcasing the efficacy of its ProSense cryoablation device in the treatment…
Lisata Therapeutics has partnered with Haystack Oncology, a Quest Diagnostics company, to use the latter’s minimal residual disease (MRD) test…
Photocure, the Bladder Cancer Company, has partnered with medtech manufacturer Richard Wolf to develop and commercialise a 4K LED high-definition…
GRAIL has completed the planned enrolment of more than 35,000 subjects for the PATHFINDER 2 study, which is evaluating the…
SkylineDx has completed patient enrolment for the landmark MERLIN_001 study of the Merlin Assay, which is set to advance melanoma…
Mainz Biomed has submitted an application to the US Food and Drug Administration (FDA) seeking breakthrough device designation for its…
The US Food and Drug Administration (FDA) will decide whether to greenlight human clinical trials for Vivos’ radiation treatment device…
BillionToOne, a molecular diagnostics company, has secured $130m in an oversubscribed, upsized Series D funding round to expand and scale…
The Fred Hutchinson Cancer Center's Translational Science & Therapeutics Division professor, Dr Matthias Stephan, has developed a biomaterial-based scaffold device…
A study led by researchers from Weill Cornell Medicine, the New York Genome Center (NYGC), NewYork-Presbyterian and Memorial Sloan Kettering…